Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-07-06 Purchase |
2021-07-08 5:21 pm |
Acumen Pharmaceuticals Inc. | ABOS | Sands Capital Ventures Discovery Fund III L.P. Sands Capital Global Venture Fund II L.P. Sands Capital Life Sciences Pulse Fund LLC SANDS FRANK M. 10% Owner |
450,000 | $14.88 | $6,696,000 | 3,417,075 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-07-06 Conversion |
2021-07-08 5:21 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Sands Capital Ventures Discovery Fund III L.P. Sands Capital Global Venture Fund II L.P. Sands Capital Life Sciences Pulse Fund LLC SANDS FRANK M. 10% Owner |
2,967,075 | $0 | 3,417,075 (Direct) |
View |
Ownership |
2021-06-30 8:10 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Sands Capital Ventures Discovery Fund III L.P. Sands Capital Global Venture Fund II L.P. Sands Capital Life Sciences Pulse Fund LLC SANDS FRANK M. 10% Owner |
0 | $0 | 2,967,075 (Direct) |
View |